New Alzheimer's Drug Studies Offer Patients Hope

By: Associated Press Email
By: Associated Press Email

TRENTON, N.J. (AP) - For Alzheimer's patients desperate for an effective treatment, several new studies starting up offer hope.

After dozens of promising experimental drugs failed, scientists think they're now on the right track, targeting the mechanisms to arrest the epidemic, mind-robbing disease.

Dr. William H. Thies, the Alzheimer's Association's top scientist, says if the new studies succeed, a medicine that slows or even stops progression of Alzheimer's might be ready in three to five years. That's only if tens of millions of dollars more are found for research and more patients join clinical studies.

Drugmakers including Merck & Co., Eli Lilly and Co. and the Roche Group are working on drugs that use different mechanisms to limit accumulation in the brain of the amyloid plaques considered the most likely cause of Alzheimer's.

Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
KOLO-TV 4850 Ampere Drive Reno, NV 89502
Copyright © 2002-2015 - Designed by Gray Digital Media - Powered by Clickability 181858091 -
Gray Television, Inc.